BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit
Provided By PR Newswire
Last update: Aug 17, 2024
NEW YORK, Aug. 16, 2024 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, both dates inclusive (the "Class Period"), of the important September 3, 2024 lead plaintiff deadline.
Read more at prnewswire.comNASDAQ:BOLT (2/21/2025, 8:04:02 PM)
0.488
-0.02 (-4.29%)
Find more stocks in the Stock Screener
